The Effect of Emergency Department Visits and Inflammatory Markers on One-Year Mortality in Patients with Heart Failure
Tóm tắt
The neurohumoral and inflammatory pathways proposed for the development and progression of heart failure (HF) remain up-to-date. We aimed to investigate the effect of emergency department (ED) visits and inflammatory markers on mortality in HF patients. Two-hundred patients with stable chronic HF followed by the cardiology clinic were included in this study. The patients were divided into two groups as patients who had visited the ED due to worsening HF symptoms within the last 6 months (ED visit Group) and who had not (No ED visit Group). The demographical properties, clinical characteristics, and laboratory values including inflammatory markers of the patients were recorded. During the follow-up period, 38 patients (19%) died. In HF patients with previous ED visits, the mortality risk was 2.091 times higher (relative risk, RR). It was identified that the HF patients who died during the follow-up had higher initial NLR (p = 0.004), IG% (p = 0.029), hs-CRP (p = 0.001), and NT-proBNP (p = 0.004) values. It was observed that the area under the curve (AUC) values, NLR (AUC: 0.705, p < 0.001), IG% (AUC: 0.652, p = 0.003), and hs-CRP (AUC: 0.732, p < 0.001) were very strong predictors of the 1-year mortality. According to the cut-off points, the mortality risk (RR) was 3.39 times higher in patients with NLR > 3.7 (95% CI 1.783–6.444), 2.39 times higher when IG% > 0.4 (95% CI 1.16–4.957), and 4,2 times higher when hs-CRP > 9.9 mg/dl (95% CI 2.16–8.16) (p < 0.05). The patients with chronic stable HF who visited the ED within the last six months and having increased NLR, IG%, and CRP levels among inflammatory markers were associated with a higher mortality risk at 1 year.
Tài liệu tham khảo
Ezekowitz, J. A., van Walraven, C., McAlister, F. A., Armstrong, P. W., & Kaul, P. (2005). Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ, 172(2), 189–194.
Siirila-Waris, K., Lassus, J., Melin, J., Peuhkurinen, K., Nieminen, M. S., & Harjola, V. P. (2006). Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. European Heart Journal, 27, 3011–3017.
Kondo, T., Okumura, T., Matsue, Y., Shiraishi, A., Kagiyama, N., Yamaguchi, T., et al. (2018). Specialty-related differences in the acute-phase treatment and prognosis in patients with acute heart failure-Insights From REALITY-AHF. Circulation Journal, 83(1), 174–181.
Sidhu, R. S., Youngson, E., & McAlister, F. A. (2014). Physician continuity improves outcomes for heart failure patients treated and released from the emergency department. JACC Heart Failure, 2(4), 368–376.
Collins, S. P., Pang, P. S., Lindsell, C. J., Kyriacou, D. N., Storrow, A. B., Hollander, J. E., et al. (2010). International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes. European Journal of Heart Failure, 12, 1253–1260.
Singer, A. J., Skopicki, H., Thode, H. C., Peacock, W.F. (2014) Hemodynamic profiles of ED patients with acute decompensated heart failure and their association with treatment. American Journal of Emergency Medicine 32, 302–305
Miró, O., Gil, V., Herrero, P., Martín-Sánchez, F. J., Jacob, J., Llorens, P., et al. (2012). Multicentric investigation of survival after Spanish emergency department discharge for acute heart failure. European Journal of Emergency Medicine, 19, 153–160.
Schrier, R. W., & Abraham, W. T. (1999). Hormones and hemodynamics in heart failure. The New England Journal of Medicine, 341, 577–585.
Park, J. J., Choi, D. J., Yoon, C. H., Oh, I. Y., Jeon, E. S., Kim, J. J., et al. (2014). Prognostic value of C-reactive protein as an inflammatory and N-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean Heart Failure registry). American Journal of Cardiology, 113(3), 511–517.
Heymans, S., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J. L., Cohen-Tervaert, J. W., et al. (2009). Inflammation as a therapeutic target in heart failure? A scientific statement from the translational research committee of the heart failure association of the European Society of Cardiology. European Journal of Heart Failure, 11(2), 119–129.
Araújo, J. P., Lourenço, P., Azevedo, A., Friões, F., Rocha-Gonçalves, F., Ferreira, A., et al. (2009). Prognostic value of high-sensitivity C-reactive protein in heart failure: A systematic review. J Card Fail, 15(3), 256–266.
Ridker, P. M. (2016). A test in context: High-sensitivity C-reactive protein. Journal of the American College of Cardiology, 67, 712–723.
Wasilewski, J., Pyka, Ł., Hawranek, M., Osadnik, T., Kurek, A., Skrzypek, M., et al. (2016). Prognostic value of neutrophil-to-lymphocyte ratio in predicting long-term mortality in patients with ischemic and nonischemic heart failure. Polskie Archiwum Medycyny Wewnetrznej, 126(3), 166–173.
Minami, Y., Kajimoto, K., Sato, N., Hagiwara, N., & ATTEND Study Investigators. (2018). Effect of elevated C-reactive protein level at discharge on long-term outcome in patients hospitalized for acute heart failure. The American Journal of Cardiology, 121(8), 961–968.
Uthamalingam, S., Patvardhan, E. A., Subramanian, S., Ahmed, W., Martin, W., Daley, M., et al. (2011). Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. American Journal of Cardiology, 107(3), 433–438.
Benites-Zapata, V. A., Hernandez, A. V., Nagarajan, V., Cauthen, C. A., Starling, R. C., & Tang, W. H. (2015). Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. American Journal of Cardiology, 115(1), 57–61.
Boralkar, K. A., Kobayashi, Y., Amsallem, M., Ataam, J. A., Moneghetti, K. J., Cauwenberghs, N., et al. (2020). Value of neutrophil to lymphocyte ratio and its trajectory in patients hospitalized with acute heart failure and preserved ejection fraction. American Journal of Cardiology, 125(2), 229–235.
Lamblin, N., Mouquet, F., Hennache, B., Dagorn, J., Susen, S., Bauters, C., et al. (2005). High-sensitivity C-reactive protein: Potential adjunct for risk stratification in patients with stable congestive heart failure. European Heart Journal, 26(21), 2245–2250.
Pellicori, P., Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., et al. (2020). High-sensitivity C-reactive protein in chronic heart failure: Patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116(1), 91–100.
Nahm, C. H., Choi, J. W., & Lee, J. (2008). Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis. Annals of Clinical and Laboratory Science, 38(3), 241–246.
Mare, T. A., Treacher, D. F., Shankar-Hari, M., Beale, R., Lewis, S. M., Chambers, D. J., et al. (2015). The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Critical Care, 19, 57.
Camplain, R., Kucharska-Newton, A., Keyserling, T. C., Layton, J. B., Loehr, L., & Heiss, G. (2018). Incidence of heart failure observed in emergency departments, ambulatory clinics, and hospitals. The American Journal of Cardiology, 121, 1328–1335.
Jong, P., Gong, Y., Liu, P. P., Austin, P. C., Lee, D. S., & Tu, J. V. (2003). Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation, 108, 184–191.
Miró, Ò., Gil, V. Í., Martín-Sánchez, F. J., Jacob, J., Herrero, P., Alquézar, A., et al. (2018). Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clinical Research in Cardiology, 107(8), 698–710.
Lee, D. S., Stukel, T. A., Austin, P. C., Alter, D. A., Schull, M. J., You, J. J., et al. (2010). Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation, 122, 1806–1814.
Gorlicki, J., Boubaya, M., Cottin, Y., Angoulvant, D., Soulat, L., Guinemer, S., et al. (2020). Patient care pathways in acute heart failure and their impact on in-hospital mortality, a French national prospective survey. IJC Heart & Vasculature, 26, 100448.
Park, B. H., Kang, Y. A., Park, M. S., Jung, W. J., Lee, S. H., Lee, S. K., et al. (2011). Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infectious Diseases, 11, 299.
Yune, H. Y., Chung, S. P., Park, Y. S., Chung, H. S., Lee, H. S., Lee, J. W., et al. (2015). Delta neutrophil index as a promising prognostic marker in out of hospital cardiac arrest. PLoS ONE, 10(3), e0120677.
Kong, T., In, S., Park, Y. S., Lee, H. S., Lee, J. W., You, J. S., et al. (2017). Usefulness of the delta neutrophil index to predict 30-day mortality in patients with upper gastrointestinal bleeding. Shock, 48, 427–435.
Kong, T., Park, Y. S., Lee, H. S., Kim, S., Lee, J. W., Yu, G., et al. (2018). Value of the Delta Neutrophil Index for predicting 28-day mortality in patients With acute pulmonary Embolism in the emergency Department. Shock, 49(6), 649–657.
Anand, I. S., Latini, R., Florea, V. G., Kuskowski, M. A., Rector, T., Masson, S., et al. (2005). C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation, 112, 1428–1434.